Opinion: Pfizer's Dividend Riskier Than It Looks, Even with a 7% Yield
Pfizer’s high dividend yield is eye-catching, but a big payout can hide hidden risks. This article explains the warni...
Compare long-run outcomes for index versus active strategies, emphasizing time horizons, persistence of outperformance, and practical takeaways.
27,723 articlesPfizer’s high dividend yield is eye-catching, but a big payout can hide hidden risks. This article explains the warni...
Carvana, known for online used-car sales, is making a curious bet on Stellantis. This article explains the rationale,...
As nephros (neph) 2025 earnings approach, investors weigh revenue growth, margins, and cash runway. This guide breaks...
In a volatile market, three names stand out for reliable income: Realty Income, EPR Properties, and Verizon. Each del...
Investors are weighing the beads-and-blood-screening company Cytosorbents as it reports 2025 earnings. This guide bre...
Investors are weighing whether the late micron technology stock still offers upside after a stunning rally. This guid...
SpaceX often grabs headlines, but the case for buying stock today isn’t as clear-cut. Here are three solid cautions t...
Investing often hinges on timing around earnings. This guide explains whether you should coca-cola stock before July ...
Lower-priced metros stay resilient as demand cools amid elevated rates. This loans-focused update surveys July data a...
A bold stake move in Hut 8 has sparked a new conversation about concentration, risk, and opportunity in crypto-relate...
Online mattress sales surge in 2026 as shoppers chase value, comfort, and easy returns. This report outlines the tren...
Solar’s most hated year is fading into a powerful five-month rally. The Invesco SOLAR ETF has surged roughly 45% sinc...